Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Regulation of apoptosis by p53 in UV-irradiated human epidermis, psoriatic plaques and senescent keratinocytes

Abstract

The carcinogenic effects of sunlight in human epidermis may be thwarted by either: transient growth arrest and repair of DNA photodamage in keratinocytes (KCs); elimination of KCs with damaged DNA via apoptosis; or by stimulating a senescence switch whereby KCs become irreversibly growth arrested. Using normal human skin organ cultures and living epidermal equivalents, we demonstrate that in the proliferative basal layer, removal of KCs via apoptosis had a rapid onset (beginning within 2 h) following UV-light exposure generating progressively greater numbers of KCs with thymine dimers as the dose of UV-light was increased; involved induction of Apaf-1, activation of caspase-3, and was dependent on p53 activation as addition of a p53 chemical inhibitor blocked the apoptotic response. Suprabasal layer KCs underwent apoptosis at much later time points (>8 h). KCs in the basal layer repaired DNA damage more rapidly than KCs in suprabasal layers. Steady state levels of p53 increased in irradiated cells, and the increase was accompanied by phosphorylation of serine 9 and serine 15, but not serine 6 residues. By contrast, cultured KCs undergoing spontaneous replicative senescence were resistant to UV-induced apoptosis. Senescent KCs constitutively contained low levels of p53, which were neither increased nor phosphorylated or acetylated after UV-exposure and possessed minimal DNA binding activity, indicative of functional inactivation. Furthermore, treatment of senescent KCs with DNA damaging agent adriamycin did not result in activation of latent p53 or apoptosis. When KCs within psoriatic plaques were examined, they resembled senescent KCs in that they expressed p53, which was not phosphorylated or acetylated. Thus, UV-light induces DNA damage in human epidermal KCs triggering p53 activation, and subsequent apoptosis involving distinct cell layers and kinetics. However, the lack of p53 activation as seen in senescent KCs and psoriatic plaques, is associated with a relative resistance of KCs to UV-induced apoptosis. In conclusion, the sensitivity and resistance of KCs to apoptosis depends not only on the location within various layers of epidermis and levels of p53, but may also involve p53 activation via post-translational modifications.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7
Figure 8
Figure 9

Similar content being viewed by others

References

  • Ananthaswamy HN, Loughlin SM, Cox P, Evans RL, Ullrich SE, Kripke ML . 1997 Nat. Med. 3: 510–514

  • Appella E, Anderson CW . 2001 Eur. J. Biochem. 268: 2764–2772

  • Atadja P, Wong H, Garkavstev I, Veillette C, Riabowol K . 1995 Proc. Natl. Acad. Sci. USA 92: 8348–8352

  • Berg RJW, Van Kranen HJ, Rebel HG, DeVries A, Van Vloten WA, VanKreijl CF, Vancer Leun JC, DeGruijl FR . 1996 Proc. Natl. Acad. Sci. USA 93: 274–278

  • Brash DE . 1996 Nature Med. 2: 525–

  • Brash DE, Ziegler A, Jonason AS, Simon JA, Kunala S, Leffell DJ . 1996 J. Invest. Dermatol.; Symp. Proc. 1: 136–142

  • Burren R, Scaletta C, Frenk E, Panizzon RG, Applegate LA . 1998 Intl. J. Cancer 76: 201–206

  • Campisi J . 1998 J. Invest. Dermatol.; Symp. Proc. 3: 1–5

  • Campisi J . 2000 In Vivo 14: 183–188

  • Chaturvedi V, Qin J-Z, Denning MF, Choubey D, Nickoloff BJ . 1999 J. Biol. Chem. 274: 23358–23367

  • Cleaver JE . 1968 Nature 218: 652–656

  • Cleaver JE, Mitchell DL . 1996 Cancer Medicine Holland JF, Frei EI, Bast RCJ, Kufe DW, Morton DL and Weichselbau RR. (eds) Williams and Wilkins: Baltimore pp 307–318

    Google Scholar 

  • Dazard JE, Piette J, Basset-Seguin N, Blanchard JM, Gandarillas A . 2000 Oncogene 19: 3693–3705

  • Dumaz N, Meek DW . 1999 EMBO J. 18: 7002–7010

  • Fukuchi Y, Kizaki M, Yamato K, Kawamura C, Umezawa A, Hata J, Nishihara T, Ikeda Y . 2001 Oncogene 20: 704–713

  • Giaccia AJ, Kastan MB . 1998 Genes Dev. 12: 2973–2983

  • Gniadecki R, Hansen M, Wulf HC . 1997 J. Invest. Dermatol. 109: 163–169

  • Gottifredi V, Shieh S, Taya Y, Prives C . 2001 Proc. Natl. Acad. Sci. USA 98: 1036–1041

  • Hall PA, McKee PH, Menage HP, Dover R, Lane DP . 1993 Oncogene 8: 203–207

  • Helander SD, Peters MS, Pittelkow MR . 1993 J. Amer. Acad. Dermatol. 29: 741–748

  • Itahana K, Dimri G, Campisi J . 2001 Eur. J. Biochem. 268: 2784–2791

  • Jonason AS, Kunala S, Price GJ, Restifo RJ, Spinelli HM, Persing JA, Leffell DJ, Tarone RE, Brash DE . 1996 Proc. Natl. Acad. Sci. USA 93: 14025–14029

  • Komarov PG, Komarova EA, Kondratov RV, Christov-Tselkov K, Coon JS, Chernov MV, Gudkov AV . 1999 Science 285: 1733–1737

  • Kubilus J, Christopher C, Pat N, Holly S, Klausner M . 1996 In Vitro Toxicol. 9: 157–166

  • Kulja KS, Lehman JM . 1995 Exp. Cell Res. 217: 336–345

  • Kulms D, Poppelmann B, Yarosh D, Luger TA, Krutmann J, Schwarz T . 1999 Proc. Natl. Acad. Sci. USA 96: 7974–7979

  • Levine AJ . 1997 Cell 88: 323–331

  • Li G, Mitchell DL, Ho VC, Reed JC, Tron VA . 1996 Amer. J. Pathol. 148: 1113–1123

  • Li G, Tron VA, Ho VC . 1998 J. Invest. Dermatol. 110: 72–75

  • Meek DW . 1998 Cell. Sig. 10: 159–166

  • Moroni MC, Hickman ES, Denchi EL, Caprara G, Colli E, Cecconi F, Muller H, Helin K . 2001 Nat. Cell Biol. 3: 552–558

  • Morris RJ, Coulter K, Tryson K, Steinberg SR . 1997 Cancer Res. 57: 3436–3443

  • Nakazawa H, English D, Randell PL, Nakazawa K, Martel N, Armstrong BK, Yamasaki H . 1994 Proc. Natl. Acad. Sci. USA 91: 360–364

  • Nickoloff BJ . 2001 J. Cut. Pathol. 28: 57–64

  • Nickoloff BJ, Denning M . 2001 J. Invest. Dermatol. 117: 1–2

  • Pavey S, Conroy S, Russell T, Gabrielli B . 1999 Cancer Res. 59: 4185–4189

  • Pavey S, Russell T, Gabrielli B . 2001 Oncogene 20: 6103–6110

  • Ponten F, Lindman H, Bostrom A, Berne B, Bergh J . 2001 J. Natl. Cancer Inst. 93: 128–133

  • Qin JZ, Chaturvedi V, Denning MF, Choubey D, Diaz MO, Nickoloff BJ . 1999 J. Biol. Chem. 274: 37957–37964

  • Qin J-Z, Bacon P, Chaturvedi V, Nickoloff BJ . 2001 J. Invest. Dermatol. 117: 898–907

  • Rees JL . 1995 J. Invest. Dermatol. 107: 883–884

  • Robles AI, Bemmels NA, Foraker AB, Harris CC . 2001 Cancer Res. 61: 6660–6664

  • Sager R . 1991 Env. Health Persp. 93: 59–62

  • Shieh SY, Ikeda M, Taya Y, Prives C . 1997 Cell 91: 325–334

  • Soengas MS, Alarcon RM, Yoshida H, Giaccia AJ, Hakem R, Mak TW, Lowe SW . 1999 Science 284: 156–159

  • Soini V, Paaco P, Letho P, Oikarinen A, Vahakansas K . 1994 Br. J. Dermatol. 131: 514–520

  • Spandau DF . 1994 Oncogene 9: 1861–1868

  • Stege H, Roza L, Vink A, Grewe M, Ruzicka T, Grether-Beck S, Krutmann J . 2001 Proc. Natl. Acad. Sci. USA 97: 1790–1795

  • Terui T, Okuyama R, Tagami H . 2001 Curr. Opin. Allerg. Clin. Immunol. 1: 461–467

  • Tornaletti S, Rozek D, Pfeifer G . 1993 Oncogene 8: 2051–2057

  • Tron VA, Trotter MJ, Tang L, Krajewska M, Reed JC, Ho VC, Li G . 1998 Am. J. Path. 153: 579–585

  • Tyner SD, Venkatachalam S, Choi J, Jones S, Ghebranious N, Igelmann H, Lu X, Soron G, Cooper B, Brayton C, Park SH, Thompson T, Karsenty G, Bradley A, Donehower LA . 2002 Nature 415: 45–53

  • Unger T, Sionov RV, Moallem E, Yee CL, Howley PM, Oren M, Haupt Y . 1999 Oncogene 18: 3205–3212

  • Webley K, Bond JA, Jones CJ, Blaydes JP, Craig A, Hupp T, Wynford-Thomas D . 2000 Mol. Cell Biol. 20: 2803–2808

  • Wolf P, Cox P, Yarosh DB, Kripke ML . 1995 J. Invest. Dermatol. 104: 287–292

  • Wrone-Smith T, Johnson T, Nelson B, Boise LH, Thompson CB, Nunez G, Nickoloff B.J . 1995 Am. J. Path. 146: 1079–1088

  • Wrone-Smith T, Mitra RS, Thompson CB, Jasty R, Castle VP, Nickoloff BJ . 1997 Am. J. Path. 151: 1321–1329

  • Yaar M, Gilchrest BA . 1998 J. Invest. Dermatol. 3s 47–51

  • Yeager TR, DeVries S, Jarrard DF, Kao C, Nakada SY, Moon TD, Bruskewitz R, Stadler WM, Meisner LF, Gilchrest KW, Newton MA, Waldman FM, Reznikoff CA . 1998 Genes Dev. 12: 163–174

  • Ziegler A, Jonason AS, Leffell DJ, Simon JA, Sharma HW, Kimmelman J, Remington L, Jacks T, Brash DE . 1994 Nature 372: 773–776

Download references

Acknowledgements

The authors thank Stephanie Russo and Jodie Carroll for manuscript preparation. This work was supported by NIH grants AR 40065 and AR 47307 (BJ Nickoloff).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Brian J Nickoloff.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Qin, JZ., Chaturvedi, V., Denning, M. et al. Regulation of apoptosis by p53 in UV-irradiated human epidermis, psoriatic plaques and senescent keratinocytes. Oncogene 21, 2991–3002 (2002). https://doi.org/10.1038/sj.onc.1205404

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1205404

Keywords

This article is cited by

Search

Quick links